VEGF and angiopoietins in diabetic glomerulopathy: How far for a new treatment?

被引：43

作者：

Dei Cas, Alessandra ^{[1
]}

Gnudi, Luigi ^{[2
]}

机构：

[1] Univ Parma, Dept Internal Med & Biomed Sci, I-43100 Parma, Italy

[2] Kings Coll London, Div Cardiovasc, London WC2R 2LS, England

来源：

METABOLISM-CLINICAL AND EXPERIMENTAL | 2012年 / 61卷 / 12期

关键词：

Diabetic nephropathy; Vascular endothelial growth factor; Angiopoietins; Therapy; ENDOTHELIAL GROWTH-FACTOR; KIDNEY-DISEASE; NEPHROTIC SYNDROME; RENAL EXPRESSION; HUMAN PODOCYTES; FACTOR RECEPTOR; A EXPRESSION; EARLY-STAGE; IN-VIVO; NEPHROPATHY;

D O I：

10.1016/j.metabol.2012.04.004

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Diabetic nephropathy (DN) is the major cause of end-stage renal disease in western countries and its prevalence continues to increase (United States Renal Data System 2010, http://www.usrds.org/). Treatments currently utilised for DN provide only partial renoprotection, hence the need to identify new targets for therapeutic intervention. Metabolic and haemodynamic abnormalities have been implicated in the pathogenesis of DN, triggering the activation of intracellular signaling molecules that lead to the dysregulation of vascular growth factors and cytokines, such as vascular endothelial growth factor (VEGF) and angiopoietins, important players in the functional and structural regulation of the glomerular filtration barrier. This review focuses on the importance of VEGF-A and angiopoietins in kidney physiology and in the diabetic kidney, exploring their potential therapeutic role in the prevention and delay of diabetic glomerulopathy. (C) 2012 Elsevier Inc. All rights reserved.

引用

页码：1666 / 1673

页数：8

共 77 条

[1] Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64) [J].

Adler, AI ;

Stevens, RJ ;

Manley, SE ;

Bilous, RW ;

Cull, CA ;

Holman, RR .

KIDNEY INTERNATIONAL, 2003, 63 (01) :225-232

[2] Role of VEGF in maintaining renal structure and function under normotensive and hypertensive conditions [J].

Advani, Andrew ;

Kelly, Darren J. ;

Advani, Suzanne L. ;

Cox, Alison J. ;

Thai, Kerri ;

Zhang, Yuan ;

White, Kathryn E. ;

Gow, Renae M. ;

Marshall, Sally M. ;

Steer, Brent M. ;

Marsden, Philip A. ;

Rakoczy, P. Elizabeth ;

Gilbert, Richard E. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (36) :14448-14453

[3] The role of podocytes in glomerular pathobiology [J].

Katsuhiko Asanuma ;

Peter Mundel .

Journal of Clinical and Experimental Nephrology, 2003, 7 (4) :255-259

[4] Reduction of VEGF-A and CTGF expression in diabetic nephropathy is associated with podocyte loss [J].

Baelde, H. J. ;

Eikmans, M. ;

Lappin, D. W. P. ;

Doran, P. P. ;

Hohenadel, D. ;

Brinkkoetter, P-T ;

van der Woude, F. J. ;

Waldherr, R. ;

Rabelink, T. J. ;

de Heer, E. ;

Bruijin, J. A. .

KIDNEY INTERNATIONAL, 2007, 71 (07) :637-645

[5] Vascular Endothelial Growth Factor Receptor 2 Direct Interaction with Nephrin Links VEGF-A Signals to Actin in Kidney Podocytes [J].

Bertuccio, Claudia ;

Veron, Delma ;

Aggarwal, Pardeep K. ;

Holzman, Lawrence ;

Tufro, Alda .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (46) :39933-39944

[6] The Alternatively Spliced Anti-Angiogenic Family of VEGF Isoforms VEGFxxxb in Human Kidney Development [J].

Bevan, Heather S. ;

van den Akker, Nynke M. S. ;

Qiu, Yan ;

Polman, Japke A. E. ;

Foster, Rebecca R. ;

Yem, Justin ;

Nishikawa, Ali ;

Satchell, Simon C. ;

Harper, Steven J. ;

Groot, Adriana C. Gittenberger-de ;

Bates, David O. .

NEPHRON PHYSIOLOGY, 2008, 110 (04) :57-67

[7] NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome [J].

Boute, N ;

Gribouval, O ;

Roselli, S ;

Benessy, F ;

Lee, H ;

Fuchshuber, A ;

Dahan, K ;

Gubler, MC ;

Niaudet, P ;

Antignac, C .

NATURE GENETICS, 2000, 24 (04) :349-354

[8] Prevalence and risk factors for micro- and macroalbuminuria in an Italian population-based cohort of NIDDM subjects [J].

Bruno, G ;

CavalloPerin, P ;

Bargero, G ;

Borra, M ;

Calvi, V ;

DErrico, N ;

Deambrogio, P ;

Pagano, G .

DIABETES CARE, 1996, 19 (01) :43-47

[9] Podocyte-secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome [J].

Clement, Lionel C. ;

Avila-Casado, Carmen ;

Mace, Camille ;

Soria, Elizabeth ;

Bakker, Winston W. ;

Kersten, Sander ;

Chugh, Sumant S. .

NATURE MEDICINE, 2011, 17 (01) :117-U294

[10] Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes [J].

Cooper, ME ;

Vranes, D ;

Youssef, S ;

Stacker, SA ;

Cox, AJ ;

Rizkalla, B ;

Casley, DJ ;

Bach, LA ;

Kelly, DJ ;

Gilbert, RE .

DIABETES, 1999, 48 (11) :2229-2239

← 1 2 3 4 5 6 7 8 →